Braze (BRZE) has been back in focus after Q4 results and guidance triggered a strong reaction from the market, with investors weighing faster organic revenue growth, heavier enterprise bookings and growing adoption of the company’s AI tools.
See our latest analysis for Braze.
At a share price of US$23.68, Braze’s 30 day share price return of 20.88% contrasts with a 90 day share price return of a 27.25% decline and a 1 year total shareholder return of a 27.67% loss. This points to improving short term momentum after a tougher period, as investors react to Q4 results, raised revenue guidance, new integrations like Wunderkind and the recently announced US$100 million share repurchase plan.
If you are weighing Braze’s recent rebound against other AI exposed opportunities, it could be a good moment to scan 66 profitable AI stocks that aren't just burning cash
With the share price still well below its 1 year level yet showing a strong 30 day rebound, and with recent AI traction, enterprise bookings and buybacks, a key question for investors is whether Braze is undervalued or whether future growth is already priced in.
Most Popular Narrative: 41.5% Undervalued
The most followed narrative values Braze at $40.50 per share, well above the last close of $23.68. This frames the recent rebound as only part of the story.
Braze's acquisition of OfferFit is expected to enhance AI-driven optimization capabilities and lead to revenue growth through deal size expansion and differentiation in the market. This investment should drive better earnings and net margins as OfferFit's sophisticated AI solutions integrate into Braze's platform.
Want to see what sits underneath that valuation gap? Revenue compounding, margin rebuild and a rich future earnings multiple all play a role. The exact mix might surprise you.
Result: Fair Value of $40.50 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this hinges on OfferFit integrating smoothly and on data sovereignty and partner pricing risks not eroding the margin and earnings assumptions behind that $40.50 fair value.
Find out about the key risks to this Braze narrative.
Next Steps
The mix of optimism and concern around Braze is clear. If you are weighing it up, consider acting promptly and review the full picture for yourself by checking the 2 key rewards and 3 important warning signs
Looking for more investment ideas?
If Braze has your attention, do not stop here. Your next move could come from scanning other focused stock ideas built from the same underlying data engine.
- Hunt for quality at a discount by checking stocks that screen as 62 high quality undervalued stocks before the crowd catches on.
- Prioritise resilience by reviewing companies that pass the 67 resilient stocks with low risk scores so your portfolio is not leaning on fragile stories.
- Spot early opportunities by browsing the screener containing 25 high quality undiscovered gems that rarely appear on mainstream shortlists.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com